Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis talks the talk with new MS digital tools

Presents real world terms in online dictionary and Chrome Extension

Novartis No Filter MS Creation 

Novartis has released new digital tools for patients with multiple sclerosis, including a first-of-its-kind Chrome extension and an online dictionary that features over 100 'real talk' definitions of MS terms.

Definitions are offered for terms that range from the fairly commonplace, such as clinical trial and caregiver, to the more medically complicated like biomarker, computerised axial tomography and gadolinium.

Extensions can add new features to a web browser or modify the functionality of a website and Chrome is the obvious browser to target. The Google program is used by an estimated 57% of web users, ahead of Safari (14%), Firefox (10%) and Internet Explorer/Edge (9%).

In the case of Novartis' MS: No Filter, the extension scans any website to find terms listed in the MS dictionary, highlights them and offers a definition and additional content.

The tools fall within the pharma firm's Living Like You campaign, the centrepiece of which is an online content hub for a global audience.

The MS: No Filter extension and dictionary were created for Novartis by comms agency Creation with input from the Living Like You blogger network.

1st February 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...

Infographics